IGF1 and Anxiety: Moreover, central IGF-1 administration decreased anxiety levels in the EPM, demonstrated as more time spent in the open arms and the center of the maze at 7 and 90 days after injection concomitantly with a higher number of entrances to the open arms of maze at the early stage of sAD.